Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
seAFOod polyp prevention trial
2010-020943-10Phase 3Terminated
- Sponsor
- University of Leeds
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin and eicosapentaenoic acid in colon adenoma and colorectal cancer (CRC) (4 arms), sponsored by University of Leeds. Primary endpoint: Participants with one or more adenomas at first surveillance colonoscopy. Started Mar 2011; status: terminated.
02
Drugs
aspirineicosapentaenoic acid
03
Conditions
colon adenomacolorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-020943-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020943-10.